Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV)

By Yahoo! Finance   |   1 month ago
Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV)

AbbVie Inc. (NYSE:ABBV) is among the top healthcare dividend stocks to buy, reaffirmed by Cantor Fitzgerald with an Overweight rating and $250 price target. Despite tax adjustments, AbbVie continues its strong dividend track record with a 2.86% yield.

Read More

Did you find this insightful?